Search Results - "Scheinman, Robert I."

Refine Results
  1. 1

    Functional differences in the mu opioid receptor SNP 118A>G are dependent on receptor splice‐variant and agonist‐specific recruitment of β‐arrestin by Patrick, Casey, Ettah, Utibeabasi, Nguyen, Vu, Hart, Caitlin, Atchley, Evan, Mallela, Krishna, Scheinman, Robert I., Monte, Andrew A.

    Published in Clinical and translational science (01-08-2024)
    “…The OPRM1 gene codes for the mu opioid receptor (MOR) and polymorphisms are associated with complex patient clinical responses. The most studied single…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Amino acid and manganese supplementation modulates the glycosylation state of erythropoietin in a CHO culture system by Crowell, Christopher K., Grampp, Gustavo E., Rogers, Gary N., Miller, Janis, Scheinman, Robert I.

    Published in Biotechnology and bioengineering (15-02-2007)
    “…The manufacture of secreted proteins is complicated by the need for both high levels of expression and appropriate processing of the nascent polypeptide. For…”
    Get full text
    Journal Article
  5. 5

    Pigmented-MDCK (P-MDCK) Cell Line with Tunable Melanin Expression: An in Vitro Model for the Outer Blood–Retinal Barrier by Kadam, Rajendra S, Scheinman, Robert. I, Kompella, Uday B

    Published in Molecular pharmaceutics (05-11-2012)
    “…Retinal pigment epithelium, which forms the outer blood–retinal barrier, is a critical barrier for transport of drugs to the retina. The purpose of this study…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins by Li, Yue, Jacques, Sarah, Gaikwad, Hanmant, Wang, Guankui, Banda, Nirmal K., Holers, V. Michael, Scheinman, Robert I., Tomlinson, Stephen, Moghimi, S. Moein, Simberg, Dmitri

    Published in Nature nanotechnology (01-02-2024)
    “…Effective inhibition of the complement system is needed to prevent the accelerated clearance of nanomaterials by complement cascade and inflammatory responses…”
    Get full text
    Journal Article
  8. 8

    LEDGF(1-326) decreases P23H and wild type rhodopsin aggregates and P23H rhodopsin mediated cell damage in human retinal pigment epithelial cells by Baid, Rinku, Scheinman, Robert I, Shinohara, Toshimichi, Singh, Dhirendra P, Kompella, Uday B

    Published in PloS one (2011)
    “…P23H rhodopsin, a mutant rhodopsin, is known to aggregate and cause retinal degeneration. However, its effects on retinal pigment epithelial (RPE) cells are…”
    Get full text
    Journal Article
  9. 9

    Nanoparticle-Binding Immunoglobulins Predict Variable Complement Responses in Healthy and Diseased Cohorts by Li, Yue, Saba, Laura, Scheinman, Robert I., Banda, Nirmal K., Holers, Michael, Monte, Andrew, Dylla, Layne, Moghimi, S. Moein, Simberg, Dmitri

    Published in ACS nano (22-10-2024)
    “…Systemic administration of nanomedicines results in the activation of the complement cascade, promoting phagocytic uptake and triggering proinflammatory…”
    Get full text
    Journal Article
  10. 10

    Feraheme (Ferumoxytol) Is Recognized by Proinflammatory and Anti-inflammatory Macrophages via Scavenger Receptor Type AI/II by Wang, Guankui, Serkova, Natalie J, Groman, Ernest V, Scheinman, Robert I, Simberg, Dmitri

    Published in Molecular pharmaceutics (07-10-2019)
    “…Feraheme (ferumoxytol), a negatively charged, carboxymethyl dextran-coated ultrasmall superparamagnetic iron oxide nanoparticle (USPIO, 30 nm, −16 mV), is…”
    Get full text
    Journal Article
  11. 11

    A New Approach for the Treatment of Arthritis in Mice with a Novel Conjugate of an Anti-C5aR1 Antibody and C5 Small Interfering RNA by Mehta, Gaurav, Scheinman, Robert I, Holers, V Michael, Banda, Nirmal K

    Published in The Journal of immunology (1950) (01-06-2015)
    “…Rheumatoid arthritis (RA) is an inflammatory autoimmune joint disease in which the complement system plays an important role. Of the several components of…”
    Get full text
    Journal Article
  12. 12

    Antibody-Dependent Complement Responses toward SARS-CoV‑2 Receptor-Binding Domain Immobilized on “Pseudovirus-like” Nanoparticles by Gaikwad, Hanmant, Li, Yue, Wang, Guankui, Li, Ronghui, Dai, Shaodong, Rester, Cody, Kedl, Ross, Saba, Laura, Banda, Nirmal K., Scheinman, Robert I., Patrick, Casey, Mallela, Krishna M.G., Moghimi, S. Moein, Simberg, Dmitri

    Published in ACS nano (28-06-2022)
    “…Many aspects of innate immune responses to SARS viruses remain unclear. Of particular interest is the role of emerging neutralizing antibodies against the…”
    Get full text
    Journal Article
  13. 13

    Functionalized STAT1 siRNA nanoparticles regress rheumatoid arthritis in a mouse model by Scheinman, Robert I, Trivedi, Ruchit, Vermillion, Sam, Kompella, Uday B

    Published in Nanomedicine (London, England) (01-12-2011)
    “…To develop and characterize an RGD peptide functionalized poly(lactide-co-glycolytic) acid (PLGA) nanosystem to deliver a STAT1 siRNA to joint tissues in a…”
    Get more information
    Journal Article
  14. 14

    Partial activation precedes apoptotic death in T cells harboring an IAN gene mutation by Lang, Julie A., Kominski, Douglas, Bellgrau, Donald, Scheinman, RobertI.

    Published in European Journal of Immunology (01-09-2004)
    “…The Biobreeding diabetes‐prone rat suffers from a profound peripheral lymphopenia and yet succumbs to a T cell‐dependent autoimmune disease. Lymphopenia…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Evaluation of Targeting Efficiency of Joints with Anticollagen II Antibodies by Lofchy, Laren A, Vu, Vivian P, Banda, Nirmal K, Ramirez, Joseline Ramos, Smith, Weston J, Gifford, Geoffrey, Gaikwad, Hanmant, Scheinman, Robert I, Simberg, Dmitri

    Published in Molecular pharmaceutics (03-06-2019)
    “…Diseases of the joints affect over 10% of the world’s population, resulting in significant morbidity. There is an unmet need in strategies for specific…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Pazopanib, a multitargeted tyrosine kinase inhibitor, reduces diabetic retinal vascular leukostasis and leakage by Thakur, Ashish, Scheinman, Robert I., Rao, Vidhya R., Kompella, Uday B.

    Published in Microvascular research (01-11-2011)
    “…To determine the efficacy of pazopanib eye drops in the streptozotocin induced diabetic retinopathy rat model. A 0.5% w/v pazopanib suspension was prepared in…”
    Get full text
    Journal Article
  20. 20

    Pleiotropic targets: the problem of shared signaling circuitry in rheumatoid arthritis disease progression and protection by Scheinman, Robert I

    Published in Future medicinal chemistry (01-04-2012)
    “…The immune response is replete with feedback control at many levels. These protective circuits are even functional within the arthritic joint, tempering…”
    Get more information
    Journal Article